Your browser doesn't support javascript.
loading
The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients.
Coffin, Donna; Gouider, Emma; Konkle, Barbara; Hermans, Cedric; Lambert, Catherine; Diop, Saliou; Ayoub, Emily; Tootoonchian, Ellia; Youttananukorn, Toong; Dakik, Pamela; Pereira, Ticiana; Iorio, Alfonso; Pierce, Glenn F.
Afiliação
  • Coffin D; World Federation of Hemophilia, Montreal, Quebec, Canada.
  • Gouider E; Service d'hématologie biologique Hemophilia Center Aziza Othmana, Faculté de Médecine de Tunis, Tunis, Tunisia.
  • Konkle B; Washington Center for Bleeding Disorders, Bloodworks Northwest, Seattle, Washington, USA.
  • Hermans C; Department of Internal Medicine, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
  • Lambert C; Haemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Diop S; Department of Hematology, National Blood Transfusion Center, University Cheikh Anta Diop, Dakar, Senegal.
  • Ayoub E; World Federation of Hemophilia, Montreal, Quebec, Canada.
  • Tootoonchian E; World Federation of Hemophilia, Montreal, Quebec, Canada.
  • Youttananukorn T; World Federation of Hemophilia, Montreal, Quebec, Canada.
  • Dakik P; World Federation of Hemophilia, Montreal, Quebec, Canada.
  • Pereira T; World Federation of Hemophilia, Montreal, Quebec, Canada.
  • Iorio A; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
  • Pierce GF; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Res Pract Thromb Haemost ; 7(8): 102264, 2023 Nov.
Article em En | MEDLINE | ID: mdl-38193052
ABSTRACT

Background:

The prevalence of hemophilia varies globally, with close to 100% of patients diagnosed in high-income countries and as low as 12% diagnosed in lower-income countries. These inequalities in the care of people with hemophilia exist across various care indicators.

Objectives:

This analysis aims to describe the clinical care outcomes of patients in the World Bleeding Disorders Registry (WBDR).

Methods:

In 2018, the World Federation of Hemophilia developed a global registry, the WBDR, to permit hemophilia treatment centers to collect clinical data, monitor patient care longitudinally, and identify gaps in management and treatment.

Results:

As of July 18, 2022, 10,276 people with hemophilia were enrolled from 87 hemophilia treatment centers in 40 countries. Nearly half (49%, n = 5084) of patients had severe hemophilia; 99% were male, 85% had hemophilia A, and 67% were from low-middle-income countries. Globally, the age of diagnosis for people with severe hemophilia has improved considerably over the last 50 years, from 82 months (∼7 years) for those born before 1980 to 11 months for those born after 2010, and most prominently, among people with severe hemophilia in low- and low-middle-income countries, the age of diagnosis improved from 418 months (∼35 years) for those born before 1970 to 12 months for those born after 2010. Overall, the age of diagnosis of people with hemophilia in low- and low-middle-income countries is delayed by 3 decades compared to patients in upper-middle-income countries and by 4 decades compared to patients in high-income countries.

Conclusion:

Data reveal large treatment and care disparities between socioeconomic groups, showing improvements when prophylaxis is initiated to prevent bleeding. Overall, care provided in low-income countries lags behind high-income countries by up to 40 years. Limitations in the interpretation of data include risk of survival and selection bias.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article